Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
Chowdhury O., O’Sullivan J., Nikolaos Barkas NB., Wang G., Buck G., Hamblin A.